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Abstract  29 
Cutaneous squamous cell carcinomas (SCCs) typically lack somatic oncogene-activating mutations 30 
and most of them contain p53 mutations. However, the presence of p53 mutations in skin 31 
premalignant lesions suggests that these represent early events during tumor progression and 32 
additional alterations may be required for SCC development. SCC cells frequently express high 33 
levels of ∆Np63α and Y-box binding 1 (YB-1 or YBX1) oncoproteins. Here, we show that 34 
knockdown of YB-1 in spontaneously immortalized HaCaT and non-metastatic SCC011 cells led to 35 
a dramatic decrease of ∆Np63α, cell detachment and death. In highly metastatic SCC022 cells, 36 
instead, YB-1 silencing induces PI3K/AKT signaling hyperactivation which counteracts the effect 37 
of YB-1 depletion and promotes cell survival. In summary, our results unveil a functional cross-talk 38 
between YB-1, ∆Np63α and the PI3K/AKT pathway critically governing survival of squamous 39 
carcinoma cells.  40 
 41 
42 
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Introduction 43 
Squamous cell carcinoma (SCC) is a treatment-refractory malignancy arising within the epithelium 44 
of different organs, that is frequently associated with overexpression of ∆Np63α oncoprotein 45 
(Rocco et al., 2006, Hibi et al., 2000). ∆Np63α is encoded by the TP63 locus, the ancestral gene of 46 
the p53 gene family that gives rise to multiple isoforms that can be placed in two categories: TA 47 
isoforms with an acidic transactivation domain and ∆N isoforms that lack this domain. Alternative 48 
splicing at the carboxy-terminal (C-terminal) generates at least three p63 variants (α, β and γ) in 49 
each class (Rossi et al., 2006, Yang et al., 1999). ∆Np63α is essential for the maintenance of the 50 
proliferative capacity of epithelial cell progenitors (Senoo et al., 2004); as these cells start to 51 
differentiate, ∆Np63α protein level gradually drops and those that no longer express ∆Np63α, loose 52 
the proliferative capacity (Koster, 2010).    53 
In squamous carcinoma, ∆Np63α up-regulation causes skin hyperplasia and abnormal keratinocyte 54 
differentiation predisposing to malignant transformation (Hibi et al., 2000; Moll and Slade, 2004).  55 
Despite its undisputed relevance in epithelial cancer, the mechanisms through which ∆Np63α 56 
executes its pro-oncogenic functions are not fully understood. However, ∆Np63α expression was 57 
shown to be induced by activation of downstream targets of EGFR activation including STAT3 58 
(Ripamonti et al., 2013) and the phosphoinositide-3-kinase (PI3K) pathway (Barbieri et al., 2003).  59 
We have recently shown that ∆Np63α interacts with the YB-1 oncoprotein and promotes 60 
accumulation of YB-1 into the nuclear compartment (Di Costanzo et al., 2012; Amoresano et al., 61 
2010). YB-1, also named YBX1, is a member of the cold shock domain (CSD) protein family, 62 
which is found in the cytoplasm and nucleus of mammalian cells, being able to shuttle between the 63 
two compartments (Eliseeva et al., 2011). The YB-1 gene, located on chromosome 1p34 (Toh et al., 64 
1998), encodes a 43 kDa protein having three functional domains: a variable NH2-terminal 65 
Alanine/Proline rich tail domain (aa 1-51), involved in transcriptional regulation, a highly 66 
Page 3 of 30
John Wiley & Sons, Inc.
Journal of Cellular Physiology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
4 
 
conserved nucleic acid binding domain (CSD, aa 51-171), and a COOH-terminal tail (B/A repeat) 67 
for RNA/ssDNA binding and protein dimerization (129-324). 68 
YB-1 is a major downstream target of Twist (Shiota et al., 2008) and c-Myc-Max complexes by 69 
recruitment to the E-box consensus sites in YB-1 promoter (Uramoto et al., 2002).  YB-1 regulates 70 
genes promoting cancer cell growth such as EGFR, Her-2, PI3KCA and MET (To et al., 2010) as 71 
well as genes linked to cancer stem cells such as those encoding the hyaluronan receptor CD44, 72 
CD49f (integrin α6) and CD104 (β4 integrin), implying that YB-1 plays a key role as oncogene by 73 
transactivating genes associated with a cancer stem cell phenotype (To et al., 2010). YB-1 protein 74 
level drastically increases during progression of several types of tumors including squamous 75 
carcinoma, thereby suggesting a role for this protein in the pathogenesis of human epithelial 76 
malignancy (Di Costanzo et al., 2012, Kolk et al., 2011). 77 
To mediate gene regulation, YB-1 translocates into the nucleus and interacts with the proximal 78 
promoter regions of its target genes (Sutherland et al., 2005; Shiota et al., 2011). Phosphorylation of 79 
serine 102 in response to MAPK and PI3K/AKT signaling promotes YB-1 nuclear translocation 80 
(Sinnberg et al., 2012). Moreover, YB-1 translocates to the nucleus when cells are exposed to 81 
cytokines, anticancer agents, hyperthermia, or UV light irradiation (Schittek et al., 2007).  82 
Herein, we present data showing the existence of a functional cross-talk between YB-1, ∆Np63α 83 
and the PI3K/AKT signaling pathway critically governing survival of squamous carcinoma cells. 84 
85 
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MATERIALS AND METHODS 86 
Plasmids 87 
The 1.1 Kb EGFR promoter luciferase plasmid was provided by Dr. A.C. Johnson (US National 88 
Cancer Institute, Massachusetts, USA). The cDNA encoding human ∆Np63α and ∆Np63α F518L 89 
were previously described (Lo Iacono et al., 2006).  90 
 91 
Cell lines, transfection  and antibodies  92 
SCC011 and SCC022 cell lines were established from cutaneous squamous carcinomas (Lefort et 93 
al.,  2007). SCC011 and SCC022 cells were cultured in RPMI supplemented with 10% fetal bovine 94 
serum at 37°C and 5% CO2. HaCaT and MDA-MB231 cells were purchased from Cell Line Service 95 
(CLS, Germany) and cultured at 37°C and 5% CO2. HaCaT cells were maintained in DMEM 96 
supplemented with 10% FBS. MDA-MB231 cells were maintained in DMEM supplemented with 97 
5% FBS.   98 
 99 
Transient transfection 100 
Lipofections were performed with Lipofectammine 2000 (Life Technologies, CA, USA), according 101 
to the manufacturer’s recommendations. 102 
YB1 transient silencing was carried out with IBONI YB-1siRNA pool (RIBOXX GmbH, Germany) 103 
and RNAiMAX reagent (Life Technologies, CA, USA), according to the manufacturer’s 104 
recommendations. Briefly, cells were seeded at 60% confluence (1.5 × 10
6
) in 100-mm dishes and 105 
transiently silenced with IBONI YB1-siRNA at 20 nM final concentration.  106 
YB-1 guide sequences:  107 
UUUAUCUUCUUCAUUGCCGCCCCC; 108 
 UUAUUCUUCUUAUGGCAGCCCCC;  109 
UUCAACAACAUCAAACUCCCCC;  110 
UCAUAUUUCUUCUUGUUGGCCCCC.  111 
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∆Np63α transient silencing was carried out with  IBONI p63-siRNA pool (RIBOXX GmbH, 112 
Germany) at 20 nM final concentration and RNAiMAX reagent (Life Technologies, CA, USA).  113 
p63 guide sequences:  114 
UUAAACAAUACUCAAUGCCCCC;  115 
UUAACAUUCAAUAUCCCACCCCC;  116 
AUCAAUAACACGCUCACCCCC;  117 
AUGAUUCCUAUUUACCCUGCCCCC. 118 
 “All Star Negative Control siRNA”, provided by Quiagen (Hilden, Germany), was used as negative 119 
control.  120 
Transfection efficiency of siRNA was quantified using BLOCK-iT™ Control Fluorescent Oligo 121 
(Life Technologies, CA, USA) at a final concentration of 20 nM using Lipofectamine RNAiMAX 122 
(Life Technologies, CA, USA).  Cells were stained with Hoechst and transfected cells detected by 123 
direct immunofluorescence. Transfection efficiency ranged between 70 and 80% .The percentage of 124 
transfected cells was estimated as the average of counts performed on 100 cells in five independent 125 
fields.  126 
Immunoblot analyses and coimmunoprecipitation  127 
Immunoblots (IB) were performed as previously described (Di Costanzo et al., 2012). Briefly, 30 128 
µg of whole cell extracts were separated by SDS-PAGE, subjected to immunoblot and incubated 129 
overnight at 4°C with antibodies.  130 
For nuclear-cytoplasmic fractionation 10 µg of nuclear and 30 µg of cytoplasmic extracts (1:3 rate) 131 
were separated by SDS-PAGE and subjected to immunoblot.  132 
All images were acquired with CHEMIDOC (Bio Rad, USA) and analyzed with the Quantity-ONE 133 
software. 134 
Coimmunoprecipitation was performed as previously described (Rossi et al., 2006). Briefly, whole 135 
HaCaT cell extracts, precleared with 30 µl of protein A-agarose (50% slurry; Roche, Manheim, 136 
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Germany), were incubated overnight at 4°C with anti-p63 (2 µg) or α-mouse IgG. The reciprocal 137 
experiment was performed with anti-YB-1(3 µg) or α-rabbit IgG (3 µg).  138 
 139 
Antibodies and chemical reagents 140 
Anti-p63 (4A4), anti-cytokeratin 1 (4D12B3), anti-GAPDH (6C5), and anti-actin (1-19) were 141 
purchased from Santa Cruz (Biotechnology Inc. CA, USA). PARP, PTEN, AKT,  pAKT 
S473
 , 142 
EGFR and STAT3 antibodies were from Cell Signaling Technology (Beverly, Massachusetts). 143 
Rabbit polyclonal YB1 (Ab12148) antibody was purchased from Abcam (Cambridge, UK).  144 
Proteasome inhibitor MG132 were purchased from Sigma-Aldrich (St Louis, MO) and used at 10 145 
µM final concentration in DMSO (Sigma-Aldrich, St Louis, MO).  LY294002 was purchased from 146 
Calbiochem (CA, USA) and used at 50 µΜ final concentration in DMSO.  147 
Cell Viability assay 148 
Cell viability was determined by the MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 149 
bromide assay (Sigma-Aldrich, St Louis, MO). Briefly, cells were seeded in 96-well plates at 2 x 150 
10
3
 and transfected with scrambled or YB-1 siRNA oligos, 48h after silencing  MTT solution 151 
(5mg/ml in PBS, 20 µl/well) was added to cells to produce formazan crystals. MTT solution was 152 
substituted by 150 µl DMSO 30 minutes later to solubilize the formazan crystals. The optical 153 
absorbance was determined at 570 nm using an iMark microplate reader (Bio-Rad, USA). The 154 
experiments were carried out in triplicate for each knockdown and compared to scrambled control 155 
(value set at 1.0). 156 
 157 
Quantitative Real Time-PCR 158 
For PCR analysis total RNA was isolated using the RNA Extraction Kit  from Qiagen (Hilden, 159 
Germany) according to the manufacturer’s instructions. RNA (2-5µg) was treated with DNAse I 160 
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(Promega, Madison USA) and used to generate reverse transcribed cDNA using SuperScript III 161 
(Life Technologies, CA, USA),  according to the manufacturer’s instructions. All samples in each 162 
experiment were reverse transcribed at the same time, the resulting cDNA diluted 1:5 in nuclease-163 
free water and stored in aliquots at –80°C until used.  164 
Real Time PCR with SYBR green detection was performed with a 7500 RT-PCR Thermo Cycler 165 
(Applied Biosystem, Foster City, USA). The thermal cycling conditions were composed of 50ºC for 166 
2 min followed by an initial denaturation step at 95ºC for 10 min, 45 cycles at 95ºC for 30s, 60ºC 167 
for 30s and 72ºC for 30s. Experiments were carried out in triplicate. The relative quantification in 168 
gene expression was determined using the 2
-∆∆Ct
 method (Livak and Schmittgen, 2011). Using this 169 
method, we obtained the fold changes in gene expression normalized to an internal control gene and 170 
relative to one control sample (calibrator). 18S was used as an internal control to normalize all data 171 
and the siCtrl was chosen as the calibrator. 172 
Appropriate no-RT and non-template controls were included in each 96-well PCR reaction and 173 
dissociation analysis was performed at the end of each run to confirm the specificity of the reaction.  174 
YB1(F):5’CGCAGTGTAGGAGATGGAGAG 175 
YB1(R):5’GAACACCACCAGGACCTGTAA 176 
∆Np63 (F):5’GGTTGGCAAAATCCTGGAG 177 
∆Np63 (R):5’GGTTCGTGTACTGTGGCTCA 178 
EGFR (F) :5’TTCCTCCCAGTGCCTGAA 179 
EGFR (R):5’GGGTTCAGAGGCTGATTGTG 180 
STAT3 (F) :5’CCTCTGCCGGAGAAACAG 181 
STAT3 (R):5’CTGTCACTGTAGAGCTGATGGAG 182 
GADD45A (F): 5’ TTTGCAATATGACTTTGGAGGA 183 
GADD45A (R): 5’ CATCCCCCACCTTATCCAT 184 
18S (F):5’TCGAGGCCCTGTAATTGGAA 185 
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18S (R):5’CTTTAATATACGCTATTGGAGCTG 186 
 187 
Luciferase reporter assay  188 
MDA-MB231 cells were co-transfected with ∆Np63α, ∆Np63α F518L and EGFR promoter-189 
luciferase reporter vector. Transfections were performed in triplicate in each assay. At 24h after 190 
transfection, cells were harvested in 1x PLB buffer (Promega, Madison, USA) and luciferase 191 
activity was measured using Dual Luciferase Reporter system (Promega, Madison, USA) using 192 
pRL-TK activity as internal control. FireFly-derived luciferase activity was normalized for 193 
transfection efficiency. Successful transfection of p63 was confirmed by immunoblotting. The 194 
average values of the tested constructs were normalized to the activity of the empty construct.  195 
 196 
Immunofluorescence and bright -field images acquisition 197 
HaCaT cells (2.5 x 10
5
) were plated in 35 mm dish, grown on micro cover glasses (BDH). At 24 198 
hours after seeding, cells were washed with cold phosphate-buffered saline (PBS) and fixed with 199 
4% paraformaldehyde (PFA) (Sigma-Aldrich, St. Louis, MO) for 15 min at 4°C. Cells were 200 
permeabilized with ice-cold 0.1% Triton X-100 for 10 min, washed with PBS and incubated with 201 
Thermo Scientific Hoechst 33342 (2'-[4-ethoxyphenyl]-5-[4-methyl-1-piperazinyl]-2,5'-bi-1H-202 
benzimidazole trihydrochloride trihydrate) for 3 min.  Images were digitally acquired at  470 nm 203 
using Nikon TE Eclipse 2000 microscope and processed using Adobe Photoshop software CS. 204 
SCC022 cells (2.5 x 10
5
) were plated in 35 mm dish and grown on micro cover glasses (BDH). At 205 
24 hours after seeding, cells were transfected with scramble , YB-1 or p63 siRNA oligos. 48 hrs 206 
after silencing cells were washed with cold phosphate-buffered saline (PBS) and fixed with 4% 207 
paraformaldehyde (PFA) (Sigma-Aldrich, St. Louis, MO) for 15 min at 4°C. Cells were 208 
permeabilized with ice-cold 0.1% Triton X-100 for 10 min and then washed with PBS. P63 was 209 
detected using a 1:200 dilution of the monoclonal antibody D9 (Santa Cruz, Biotechnology Inc., 210 
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CA, USA). YB-1 was detected using 1:100 dilution of the YB1 antibody (Ab12148). After 211 
extensive washing in PBS, the samples were incubated with Cy3-conjugated anti-mouse  (red) and 212 
Cy5-conjugated anti-rabbit IgGs (green)  at room temperature for 30 min. Cells were incubated with 213 
Hoechst 33342 (2'-[4-ethoxyphenyl]-5-[4-methyl-1-piperazinyl]-2,5'-bi-1H-benzimidazole 214 
trihydrochloride trihydrate) (Thermo Scientific) for 3 min. Images were digitally acquired and 215 
processed using Adobe Photoshop software CS. 216 
 217 
Cell motility assay 218 
SCC022 cells were cultured on 35-mm dishes (Corning, NY) at 2x10
4
 cells/dish density. 219 
∆Np63α or YB1 transient silencing were performed as described above. After 24 h from silencing 220 
cell migration tests were performed via an Olympus IX81 inverted microscope equipped with a 10X 221 
objective and an integrated stage incubator (Okolab, Italy). Images of selected positions of the cell 222 
culture were collected in bright field for 16 h with 5-min frame intervals. All of the collected data 223 
were processed with the Olympus imaging software Cell^R. To quantify the cell speed (µm/min), 224 
time-lapse acquisitions were processed by the dedicated software add-in (TrackIT). The average 225 
speed per cell was calculated from the length of the path divided by time. An average number of 60 226 
cells were analyzed for each condition.  227 
 228 
229 
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 230 
Results 231 
YB-1 knockdown in HaCaT cells 232 
We have previously shown that ∆Np63α interacts with YB-1 in human squamous carcinoma cells 233 
and promotes accumulation of full length YB-1 protein (50 kDa) in the nuclear compartment (Di 234 
Costanzo et al., 2012). We first validated the interaction between YB-1 and ∆Np63α in non 235 
transformed HaCaT keratinocytes by co-immunoprecipitation assay (Supplementary Fig. 1). Then, 236 
we examined the effect of YB-1 silencing in mitotically active HaCaT keratinocytes. Interestingly, 237 
at 48 hrs of silencing we observed massive cell detachment (Figure 1A, upper panel) associated 238 
with a high proportion of condensed and fragmented nuclei (Figure 1A, lower panel). Western blot 239 
analysis showed a significant reduction of ∆Np63α protein level and PARP1 proteolytic cleavage 240 
(Figure 1B, left panel) indicating that YB-1 is critical for keratinocyte survival.  241 
∆Np63α is known to sustain survival in squamous cell carcinoma (Rocco et al., 2006, Hibi et al., 242 
2000) and up-regulate cell adhesion-associated genes (Carrol et al., 2006). To rule out the 243 
possibility that YB-1 silencing induces cell death by merely reducing the level of ∆Np63α, we 244 
knocked down ∆Np63α expression in HaCaT cells by RNA interference. According to previous  245 
studies (Barbieri et al., 2006), we observed neither cell detachment (Figure 1A, upper panel) nor 246 
PARP1 activation (Figure 1B, right panel) clearly indicating that apoptosis, induced by YB-1 247 
depletion, cannot be simply ascribed to the lack of ∆Np63α.  248 
Next, we evaluated the level of ∆Np63α-specific transcript following YB-1 knockdown by Real 249 
Time quantitative PCR (RT-qPCR) and we found that it was drastically reduced (Figure 1C). After 250 
p63 silencing, instead, YB-1 transcript level was slightly enhanced (Figure 1D) while  the mRNA of 251 
GADD45A, a gene induced by stressful conditions and used as control, was enhanced in both 252 
experiments (Figure 1C and D).  253 
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 254 
YB-1 knockdown in squamous carcinoma cells 255 
Next, we used RNA interference to explore the function of YB-1 in squamous cell carcinoma 256 
(SCC). SCC011 and SCC022 are cell lines derived from cutaneous squamous carcinomas (Lefort et 257 
al., 2007). SCC022 are highly metastatic and, when subcutaneously injected in nude mice, form 258 
large tumors. SCC011 cells, instead, generate only keratin pearls (C. Missero, personal 259 
communication).  260 
Similarly to what observed in HaCaT cells, YB1-depleted SCC011 cells detached from the plate 261 
generating abundant cellular debris (Figure 2A, upper panel) and exhibited a reduced level of 262 
∆Np63α protein (Figure 2B). PARP1 cleavage was barely detectable (Figure 2B). On the other 263 
hand, we have previously demonstrated that p63 knockdown has no apparent effect on SCC011 cell 264 
viability (Di Costanzo et al., 2012).  265 
Surprisingly, SCC022 cells looked healthy and tightly adherent to the plate after YB1 silencing 266 
(Figure 2A, lower panel). Moreover, as detected by immunoblot analysis, the expression level of 267 
∆Np63α protein was significantly increased (Figure 2B).  Interestingly, ∆Np63α transcript in 268 
SCC011 was reduced while in SCC022 it was 2.1-fold higher than control (Figure 2C).  269 
Analysis of cell viability by the MTT assay showed that after 48 hrs of YB-1 knockdown the 270 
percentage of viability of SCC022 cells was 70% of the control, while it was reduced to 10% in 271 
HaCaT and SCC011 cells (Figure 4C).  272 
We have also performed p63 knockdown in SCC022 cells and, as expected, we observed 273 
accumulation of YB-1 in the cytoplasm without any apparent effect on cell viability 274 
(Supplementary Fig. 2).  275 
We also determined the influence of ∆Np63α or YB-1 silencing on SCC022 cell motility by time-276 
lapse microscopy using siRNA-based silencing of endogenous proteins. According to our previous 277 
observations made on SCC011 cells (Di Costanzo et al., 2012) ∆Np63α silenced cells display 278 
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higher speeds (p < 0.01) than control cells. Conversely,  SCC022 cell motility was unaffected by 279 
YB-1 depletion (Supplementary Fig. 3). 280 
 281 
YB-1 silencing hyper-activates the PI3K/AKT signaling pathway in SCC022 cells 282 
∆Np63α is a target of the phosphoinositide-3-kinase (PI3K) pathway downstream of the Epidermal 283 
Growth Factor Receptor (Barbieri et al., 2003). We hypothesized an involvement of the PI3K/AKT 284 
pathway in the upregulation of ∆Np63α observed in SCC022 cells following YB-1 silencing, and 285 
we looked for changes in the phosphorylation status of AKTSer473. Interestingly, unlike HaCaT and 286 
SCC011, SCC022 cells exhibited constitutive phosphorylation of AKTSer473 which was reproducibly 287 
potentiated following YB-1 depletion (Figure 3A and B) suggesting that YB-1 expression restrains 288 
AKT activation. To corroborate this result, we treated YB1-silenced SCC022 cells with Ly294002, 289 
a highly selective PI3K inhibitor. Remarkably, Ly294002 treatment counteracted AKT 290 
hyperphosphorylation and the increase of ∆Np63α protein level in response to YB-1 silencing 291 
(Figure 3B).  Moreover, it resulted in cell death and detachment (data not shown). Importantly, 292 
Ly294002 treatment alone had no apparent effect on ∆Np63α level and SCC022 cell viability 293 
(Figure 3B and data not shown). Quantification of ∆Np63α transcript in YB-1 depleted SCC022 294 
cells, treated or not with LY294002, showed that the increase of ∆Np63α transcription was strictly 295 
dependent on the PI3K/AKT pathway (Figure 3B). Moreover, inhibition of the proteasome activity 296 
with MG132 did not significantly enhance ∆Np63α protein level in YB1-silenced SCC022 cells, 297 
thereby confirming that ∆Np63α up-regulation was almost exclusively at transcriptional level 298 
(Supplementary Fig. 4).  299 
The PI3K/AKT signaling pathway is negatively regulated by the phosphatase and tensin homologue 300 
PTEN (Song et al., 2012). To further investigate on the ability of SCC022 cells to escape from 301 
death following YB-1 depletion, we compared the protein level of PTEN among HaCaT, SCC011 302 
Page 13 of 30
John Wiley & Sons, Inc.
Journal of Cellular Physiology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
14 
 
and SCC022 cell lines. Compared to HaCaT and SCC011 cells, the  level of PTEN protein in 303 
SCC022 cells was very low, accounting for their high basal level of AKTSer473 phosphorylation 304 
(Figure 3E). Furthermore, YB-1 silencing resulted in increased levels of cytoplasmic PTEN in 305 
HaCaT and SCC011 cells, while no effects on PTEN protein level was observed in YB-1 silenced 306 
SCC022 cells (Figure 3E).  307 
 308 
Cross-talk of ∆Np63α and YB-1 with EGFR/STAT3 and  PI3K/AKT signaling pathways  309 
In pancreatic cancer cells, ∆Np63α expression was shown to induce the Epidermal Growth Factor 310 
Receptor (EGFR) (Danilov et al.,  2011). As we observed a PI3K-dependent increase of ∆Np63α in 311 
SCC022 cells upon YB-1 silencing, we decided to evaluate the level of EGFR and its direct 312 
downstream target STAT3 in SCC022 cells upon YB-1 or ∆Np63α silencing. As shown in Figure 4, 313 
along with ∆Np63α, YB-1 depletion up-r gulates EGFR and STAT3 both at protein (Figure 4A) 314 
and RNA level (Figure 4B). Real Time PCR assay in SCC022 cells clearly shows that YB-1 315 
silencing results in about 2 and 3.5 fold induction of EGFR and STAT3 transcripts, respectively 316 
(Figure 4B). Following ∆Np63α silencing, instead, the expression of both EGFR and STAT3 was 317 
switched off although the level of YB-1 protein remained unaltered (Figure 4A). These results 318 
suggest that ∆Np63α is a major activator of the EGFR/STAT3 axis in squamous carcinoma cells. 319 
Accordingly, in SCC011 and HaCaT cells where YB-1 silencing reduces ∆Np63α, EGFR and 320 
STAT3 transcription was also reduced (Supplementary Fig. 5A and B).  321 
To confirm the ability of ∆Np63α to regulate EGFR gene expression we performed transient 322 
transfection and luciferase reporter assays in MDA-MB231 breast cancer cells expressing no 323 
detectable p63.  MDA-MB231 cells were transiently transfected with the EGFR promoter-luciferase 324 
vector and increasing amount of expression plasmid encoding wild type ∆Np63α  or its mutant 325 
form bearing  the F to L substitution at position 518 of the SAM domain. This mutant was 326 
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previously described to be transactivation defective (Radoja et al., 2007). Remarkably, wild type 327 
but not mutant ∆Np63α protein induced luciferase activity, in a dose-dependent manner (Figure 4C 328 
and D). Moreover, Western blot analysis of extracts from MDA-MB231 breast cancer cells 329 
transiently transfected with ∆Np63α showed induction of both EGFR and STAT3 endogenous 330 
proteins, confirming that EGFR and STAT3 expression are induced by ∆Np63α (Figure 4E).   331 
 332 
DISCUSSION 333 
YB-1 is a versatile protein associated with many malignancies. However, because of its 334 
multifunctional character, the role of YB-1 in neoplastic cell growth remains elusive (Bader et al., 335 
2006).  336 
Our previous (Di Costanzo et al., 2012) and present data show that ∆Np63α hyper-expression, as it 337 
occurs in squamous carcinoma cells, is associated with YB-1 nuclear localization where it is 338 
expected to play a pro-proliferative role. In the present manuscript we show that YB-1 depletion has 339 
a strong negative impact on cell survival of both immortalized HaCaT keratinocytes and non-340 
metastatic SCC011 squamous carcinoma cells. Interestingly, in HaCaT and SCC011 cells, YB-1 341 
knockdown causes a significant reduction of ∆Np63α transcription (Yang et al., 1999; Senoo et al., 342 
2004). However, in HaCaT and SCC cells, ∆Np63α knockdown is not sufficient to trigger cell 343 
death thereby indicating that YB-1, in keratinocytes, plays additional p63-independent pro-survival 344 
functions. 345 
Surprisingly, in highly metastatic SCC022 cells, YB-1 silencing does not result in cell death. 346 
Strikingly, in these cells, YB-1 silencing potentiates AKT activation suggesting that YB-1 can act 347 
as a negative regulator of the PI3K/AKT signaling pathway and its loss allows PI3K/AKT-348 
dependent induction of pro-survival genes, including ∆Np63α. Interestingly, the low level of 349 
endogenous PTEN observed in SCC022 cells can likely explain the constitutive activation of the 350 
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PI3K/AKT pathway observed in this cell line. Remarkably, we have observed only in HaCaT and 351 
SCC011 cells a strong activation of PTEN in response to YB-1 depletion. In SCC022 cells, instead, 352 
where PI3K/AKT hyper-activation sustains ∆Np63α protein level, we did not observe any increase 353 
of PTEN after YB-1 depletion. However, at this stage, we can hypothesize that, in this cell line, 354 
PTEN cannot be up-regulated because of epigenetic or other inactivating mechanisms.  355 
The evidence that PI3K/AKT hyperactivation in SCC022 cells is responsible for ∆Np63α 356 
transcriptional induction is in line with previous studies showing that ∆Np63α is positively 357 
regulated by the PI3K pathway (Barbieri et al., 2003). However, it is important to remind that 358 
∆Np63α has been shown to repress the expression of PTEN (Leonard et al., 2011). Accordingly, in 359 
PTEN-proficient HaCaT and SCC011 cells, where YB-1 silencing causes a decrease of ∆Np63α, 360 
we observed an increase in the level of PTEN protein which is expected to restrain signaling by the 361 
PI3K pathway. 362 
In summary, our results indicate that, being able to sustain ∆Np63α gene expression, YB-1 is part 363 
of a complex molecular network linking ∆Np63α to the PI3K/AKT/PTEN pathway and that 364 
establishment of a positive feedback loop coupling induction of ∆Np63α expression with 365 
PI3K/AKT activation may be a relevant step in progression of squamous carcinogenesis.  366 
An important finding of our work is the observation that ∆Np63α controls the expression of the 367 
Epidermal Growth Factor Receptor switching-on the entire EGFR/STAT3 axis. Accordingly, in 368 
normal adult epidermis, the EGFR is predominantly expressed in basal keratinocytes and signaling 369 
events elicited by it are known to affect their proliferation and migration (Bito et al., 2011). 370 
∆Np63α, therefore, represents an important molecular connection between YB-1, the PI3K/AKT 371 
and the EGFR/STAT3 signaling pathways. We can postulate that constitutive activation of 372 
PI3K/AKT, such as in PTEN-deficient cells, may likely cause persistence of ∆Np63α which can 373 
induce keratinocyte hyper-proliferation by impinging on the EGFR/STAT3 pathway. Interestingly, 374 
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in physiological conditions EGF-dependent and PI3K/AKT pathways are both required for efficient 375 
skin wound re-epithelialization (Haase et al., 2003). Moreover, EGFR/STAT3 inhibition was shown 376 
to be unable to induce apoptosis (Bito et al., 2003) thereby providing a plausible explanation of why 377 
∆Np63α silencing alone was not sufficient to induce cell death in our experimental settings.  378 
In summary, we have presented clear evidences to suggest that YB-1 can play a role in skin 379 
carcinogenesis. However, the molecular basis of cancer can widely vary and the ability of YB-1 to 380 
control multiple and overlapping pathways raises concerns about the consideration of YB-1 as an 381 
attractive target for therapy against metastatic squamous cancer. In particular, our results indicate 382 
that YB-1 knockdown in cells whose oncogenic transformation depends on PI3K/AKT constitutive 383 
activation is expected to enhance rather than arrest metastatic progression. Association of YB1-384 
targeted therapy with drugs that target the PI3K and/or EGFR pathway should be evaluated as a 385 
valuable strategy to treat squamous carcinoma. In vivo experiments will help to clarify this relevant 386 
point.  387 
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Figures Legend 492 
 493 
Figure 1. YB-1 knockdown affects HaCaT cell survival. (A) upper panel, Phase-Contrast 494 
imaging and  Hoechst staining (lower panel) showing HaCaT keratinocyte cells transfected with 495 
scrambled, YB-1 or p63 siRNA oligos. (B) Representative immunoblot analyses of HaCaT 496 
keratinocytes transfected with YB1 (upper panel), p63 (lower panel) or scrambled (siCtrl) 497 
siRNA oligos, respectively.  48 hours after silencing whole cell extracts were immunoblotted 498 
with YB-1, p63 and PARP antibodies. Actin was used as a loading control. Bar graphs are 499 
quantitative densitometric analyses of four indipendent Western blots. The blots were 500 
normalized to actin and the fold-changes of protein levels are reported in comparison to control 501 
(value set at 1.0). P-value <0.05 is represented by *; P-value <0.01 is represented by **. (C) 502 
Quantitative real-time PCR analysis of HaCaT keratinocytes transfected with scrambled or YB-1 503 
siRNA oligos. GADD45A mRNA level was measured as a control. (D) Quantitative Real-time 504 
PCR analysis of HaCaT keratinocytes transfected with scrambled or p63 siRNA oligos. In both 505 
experiments data were analyzed according to the fold-changes compared to scrambled control 506 
(value set at 1.0) using the 2
-∆∆Ct
 method. P-value <0.05 is represented by *; P-value <0.01 is 507 
represented by **. 508 
 509 
Figure 2. YB-1 knockdown in SCC011 and SCC022 squamous carcinoma cells. (A) Phase-510 
contrast imaging showing SCC011 (upper panel) and SCC022 (lower panel) cells at 48 hours 511 
post-YB1 silencing.  (B) Representative immunoblot analysis of SCC011 or SCC022 cells 512 
transfected with scrambled or YB-1 siRNA oligos. 48 hours after silencing whole cell lysates 513 
were immunoblotted with YB-1, p63 and PARP antibodies. GAPDH was used as a loading 514 
control. Bar graph is a quantitative densitometric analysis of four indipendent Western blots. The 515 
blots were normalized to GAPDH and the fold-changes of protein levels are reported in 516 
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comparison to control (value set at 1.0). P-value <0.05 is represented by *; P-value <0.01 is 517 
represented by **. (C) Quantitative Real-time PCR analysis of SCC011 (left panel) and SCC022 518 
cells (right panel) transfected with scrambled or YB-1 siRNA oligos. Data were analyzed 519 
according to the fold-changes compared to scrambled control (value set at 1.0) using the 2
-∆∆Ct
 520 
method. P-value <0.05 is represented by *; P-value <0.01 is represented by **. (D) Effect of 521 
YB1 silencing on the viability of HaCaT and SCC cells. Cell viability was assessed by MTT 522 
assay following 48 hours of YB-1 silencing. Data are represented as the mean +/- SD from three 523 
independent experiments. The asterisk indicates P-value<0.05. 524 
 525 
Figure 3. YB-1 knockdown enhances pAKT
S473  
in SCC022 squamous carcinoma. (A) 526 
Immunoblot analysis of HaCaT, SCC011 and SCC022 cells transfected with scrambled or YB1-527 
siRNA oligos.  48 hours after silencing whole cell extracts were immunoblotted with YB-1, 528 
pAKT
S473 
and AKT antibodies. Actin was used as a loading control. (B) SCC022 cells were 529 
transfected with scrambled or YB-1 siRNA oligos transfection. After 42 hrs cells were treated 530 
with LY294002 for 6 hrs. Whole cell extracts were analyzed by immunoblotting with YB-1, 531 
pAKT
S473
, p63 and AKT antibodies. Actin was used as loading control. (C) Quantitative Real-532 
time PCR of ∆Np63 mRNA levels. ∆Np63 mRNA levels were analyzed according to the fold-533 
changes compared to scrambled control (value set at 1.0) using the 2
-∆∆Ct
 method. P-value < 0.05 534 
is represented by *; P-value < 0.01 is represented by **. DMSO was used as control (D) 535 
Immunoblot analysis of HaCaT, SCC011 and SCC022 cells. Whole cell extracts were 536 
immunoblotted with, PTEN,  pAKT
S47 
, and AKT antibodies. GAPDH was used as loading 537 
control. (E) Nuclear and cytoplasmic fractionation of extracts from control or YB-1 silenced 538 
HaCaT, SCC011 and SCC022 cells are shown in Figure 5A. Fractions were analysed by 539 
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immunoblotting with PTEN antibody. GAPDH and PARP were used as cytoplasmic and nuclear 540 
controls, respectively. 541 
 542 
Figure 4. Cross-talk of ∆Np63α and YB-1 with EGFR/STAT3 pathway. (A) Immunoblot 543 
analysis of SCC022 cells transfected with scramble, YB-1 or p63 siRNA oligos. Whole cell 544 
extracts were immunoblotted with, YB-1, p63, EGFR, STAT3 antibodies. Actin was used as a 545 
loading control. (B)  Quantitative Real-time PCR analysis of SCC022 cells transfected with 546 
scrambled or YB-1 siRNA oligos. YB-1, EGFR and STAT3 mRNA levels  were analyzed 547 
according to the fold-changes compared to scrambled control (value set at 1.0) using the 2
-∆∆Ct
 548 
method. P-value < 0.05 is represented by *; P-value < 0.01 is represented by **. (C) Luciferase 549 
assay of EGFR-promoter activity in MDA-MB231 cells. Cells were  transiently transfected with 550 
1µg of luciferase reporter plasmid and the indicated amounts of ∆Np63α or ∆Np63α F518L 551 
plasmids. Luciferase assay was performed at 48 hrs post-transfection. Values are the mean +/- 552 
SD of three independent experimental points. (D) Representative immunoblotting showing the 553 
level of ∆Np63α in transfected MDA-MB231 cell extracts used for the luciferase assay shown in 554 
7C. GAPDH immunodetection was used as loading control. (E) MDA-MB231 cells were 555 
transfected with empty vector or ∆Np63α plasmids. At 24h post-transfection cells were 556 
harvested and whole cell extracts were analyzed by immunoblotting with p63, STAT3 and 557 
EGFR antibodies. Actin was used as a loading control. 558 
 559 
Supplementary Figures 560 
S1. YB-1 and ∆Np63α coimmunoprecipitation in HaCaT cells. (A) Extracts from HaCaT 561 
cells were immunoprecipitated with anti-p63 antibodies and the immunocomplexes were blotted 562 
and probed with anti-YB-1, as indicated. (B) Extracts from HaCaT cells were 563 
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immunoprecipitated with anti-YB-1 antibodies and the immunocomplexes were blotted and 564 
probed with anti-p63. Samples with no antibody (no Ab) or irrelevant α-mouse and α-rabbit 565 
antibodies were included as controls. (C) Immunoblot analysis of YB-1 level in HaCaT cells 566 
treated with proteasome inhibitor MG132 for 6h (5µM final concentration). 36kDa and 43kDa 567 
YB-1 forms are reduced with concomitant accumulation of full-length YB-1 50kDa band 568 
showing the identity of YB-1 bands. 569 
 570 
S2. YB-1 and p63 knockdown in SCC022 cells. (A) Immunofluorescence assay in SCC022 571 
cells transfected with scrambled, YB-1 or p63 siRNA oligos. YB1 was detected using anti-YB-1 572 
and secondary anti-rabbit Cy5-conjugated (green) antibodies. p63 was detected using anti-p63 573 
and secondary anti-mouse Cy3-conjugated (red) antibodies. Hoechst was used to stain nuclei. (B) 574 
(upper panel) SCC022 cells were incubated with normal mouse serum and secondary anti-mouse 575 
Cy3-conjugated (red) antibodies; (lower panel) SCC022 cells were incubated with normal rabbit 576 
serum and secondary anti-rabbit Cy5-conjugated (green) antibodies. 577 
 578 
S3. Effect of p63 and YB-1 silencing on SCC022 cells migration speed. (A) Motility assay on 579 
SCC022 cells after transient silencing of p63 and YB-1 performed by time-lapse microscopy. 580 
After 24 h of incubation with siRNA oligos, cell migration assay was performed. Averaged cell 581 
speeds after 16 h of observation are reported. Horizontal lines and boxes and whiskers represent 582 
the medians, 25th/75th, and 5th/95th percentile, respectively. P-value < 0.01 is represented by 583 
**. Only statistically different doubles are marked. (B) Immunoblot analysis of ∆Np63α and 584 
YB-1 protein levels in SCC022 cells after 40 h of ∆Np63α or YB-1 silencing and used in cell 585 
migration assay. Cell extracts were blotted and probed with anti-p63 or anti-YB-1 antibodies. 586 
GAPDH was used as a loading control. ∆Np63α protein band was almost undetectable while 587 
YB-1 protein was reduced to 40%, as assed by densitometric scanning.  588 
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 589 
S4. Proteasome activity is not involved in ∆Np63α up-regulation upon YB-1 silencing. 590 
Immunoblot analysis of SCC022 cells transfected with scrambled or YB1-siRNA oligos and 591 
treated with MG132 (6 hrs) after 42 hours of YB-1 silencing cells. Whole cell extracts were 592 
immunoblotted with YB-1 and p63 antibodies. Actin was used as loading control.  593 
 594 
 595 
S5. Effect of YB-1 silencing on EGFR/STAT3 mRNA levels in SCC011 and HaCaT cells. 596 
Quantitative Real-time  PCR analysis of (A) SCC011 cells and (B) HaCaT cells transfected with 597 
scrambled or YB-1 siRNA oligos. YB-1, EGFR and STAT3 mRNA levels were analyzed 598 
according to the fold-changes compared to scrambled control (value set at 1.0) using the 2
-∆∆Ct
 599 
method. P-value < 0.05 is represented by *; P-value < 0.01 is represented by **. 600 
 601 
 602 
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YB-1 knockdown affects HaCaT cell survival. (A) upper panel, Phase-Contrast imaging and  Hoechst staining 
(lower panel) showing HaCaT keratinocyte cells transfected with scrambled, YB-1 or p63 siRNA oligos. (B) 
Representative immunoblot analyses of HaCaT keratinocytes transfected with YB1 (upper panel), p63 (lower 
panel) or scrambled (siCtrl) siRNA oligos, respectively.  48 hours after silencing whole cell extracts were 
immunoblotted with YB-1, p63 and PARP antibodies. Actin was used as a loading control. Bar graphs are 
quantitative densitometric analyses of four indipendent Western blots. The blots were normalized to actin 
and the fold-changes of protein levels are reported in comparison to control (value set at 1.0). P-value 
<0.05 is represented by *; P-value <0.01 is represented by **. (C) Quantitative real-time PCR analysis of 
HaCaT keratinocytes transfected with scrambled or YB-1 siRNA oligos. GADD45A mRNA level was measured 
as a control. (D) Quantitative Real-time PCR analysis of HaCaT keratinocytes transfected with scrambled or 
p63 siRNA oligos. In both experiments data were analyzed according to the fold-changes compared to 
scrambled control (value set at 1.0) using the 2-∆∆Ct method. P-value <0.05 is represented by *; P-value 
<0.01 is represented by **.  
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YB-1 knockdown in SCC011 and SCC022 squamous carcinoma cells. (A) Phase-contrast imaging showing 
SCC011 (upper panel) and SCC022 (lower panel) cells at 48 hours post-YB1 silencing.  (B) Representative 
immunoblot analysis of SCC011 or SCC022 cells transfected with scrambled or YB-1 siRNA oligos. 48 hours 
after silencing whole cell lysates were immunoblotted with YB-1, p63 and PARP antibodies. GAPDH was used 
as a loading control. Bar graph is a quantitative densitometric analysis of four indipendent Western blots. 
The blots were normalized to GAPDH and the fold-changes of protein levels are reported in comparison to 
control (value set at 1.0). P-value <0.05 is represented by *; P-value <0.01 is represented by **. (C) 
Quantitative Real-time PCR analysis of SCC011 (left panel) and SCC022 cells (right panel) transfected with 
scrambled or YB-1 siRNA oligos. Data were analyzed according to the fold-changes compared to scrambled 
control (value set at 1.0) using the 2-∆∆Ct method. P-value <0.05 is represented by *; P-value <0.01 is 
represented by **. (D) Effect of YB1 silencing on the viability of HaCaT and SCC cells. Cell viability was 
assessed by MTT assay following 48 hours of YB-1 silencing. Data are represented as the mean +/- SD from 
three independent experiments. The asterisk indicates P-value<0.05.  
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YB-1 knockdown enhances pAKTS473  in SCC022 squamous carcinoma. (A) Immunoblot analysis of HaCaT, 
SCC011 and SCC022 cells transfected with scrambled or YB1-siRNA oligos.  48 hours after silencing whole 
cell extracts were immunoblotted with YB-1, pAKTS473 and AKT antibodies. Actin was used as a loading 
control. (B) SCC022 cells were transfected with scrambled or YB-1 siRNA oligos transfection. After 42 hrs 
cells were treated with LY294002 for 6 hrs. Whole cell extracts were analyzed by immunoblotting with YB-1, 
pAKTS473, p63 and AKT antibodies. Actin was used as loading control. (C) Quantitative Real-time PCR of 
∆Np63 mRNA levels. ∆Np63 mRNA levels were analyzed according to the fold-changes compared to 
scrambled control (value set at 1.0) using the 2-∆∆Ct method. P-value < 0.05 is represented by *; P-value 
< 0.01 is represented by **. DMSO was used as control (D) Immunoblot analysis of HaCaT, SCC011 and 
SCC022 cells. Whole cell extracts were immunoblotted with, PTEN,  pAKTS47 , and AKT antibodies. GAPDH 
was used as loading control. (E) Nuclear and cytoplasmic fractionation of extracts from control or YB-1 
silenced HaCaT, SCC011 and SCC022 cells are shown in Figure 5A. Fractions were analysed by 
immunoblotting with PTEN antibody. GAPDH and PARP were used as cytoplasmic and nuclear controls, 
respectively.  
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Cross-talk of ∆Np63α and YB-1 with EGFR/STAT3 pathway. (A) Immunoblot analysis of SCC022 cells 
transfected with scramble, YB-1 or p63 siRNA oligos. Whole cell extracts were immunoblotted with, YB-1, 
p63, EGFR, STAT3 antibodies. Actin was used as a loading control. (B)  Quantitative Real-time PCR analysis 
of SCC022 cells transfected with scrambled or YB-1 siRNA oligos. YB-1, EGFR and STAT3 mRNA levels  were 
analyzed according to the fold-changes compared to scrambled control (value set at 1.0) using the 2-∆∆Ct 
method. P-value < 0.05 is represented by *; P-value < 0.01 is represented by **. (C) Luciferase assay of 
EGFR-promoter activity in MDA-MB231 cells. Cells were  transiently transfected with 1µg of luciferase 
reporter plasmid and the indicated amounts of ∆Np63α or ∆Np63α F518L plasmids. Luciferase assay was 
performed at 48 hrs post-transfection. Values are the mean +/- SD of three independent experimental 
points. (D) Representative immunoblotting showing the level of ∆Np63α in transfected MDA-MB231 cell 
extracts used for the luciferase assay shown in 7C. GAPDH immunodetection was used as loading control. 
(E) MDA-MB231 cells were transfected with empty vector or ∆Np63α plasmids. At 24h post-transfection cells 
were harvested and whole cell extracts were analyzed by immunoblotting with p63, STAT3 and EGFR 
antibodies. Actin was used as a loading control.  
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